Printer Friendly

U.S. DRUG TESTING EXTENDS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT WITH NAVAL RESEARCH LABORATORY

 RANCHO CUCAMONGA, Calif., Nov. 16 /PRNewswire/ -- Gary S. Wolff, chief financial officer of U.S. Drug Testing Inc., announced today that it has signed an amendment to the Cooperative Research and Development Agreement (CRDA) with the Naval Research Laboratory.
 This amendment allows the CRDA to be extended for a period of up to eight months. During the initial phase of this extension, research and development will focus on testing for drugs of abuse using saliva as the test medium.
 The original CRDA was signed between the two parties in April 1991 in order to cooperate in the research and development of instruments to detect drugs of abuse using the Flow Immunosensor Technology, developed by scientists at NRL and licensed to the company in January of 1991.
 Thus far, the CRDA has resulted in the company submitting four 510(k) applications to the Food and Drug Administration (FDA). The company has received pre-market approval from the FDA for the Flow Immunoassay System as well as the attendant assays specific for the detection of cocaine and opiates in urine samples. The assay specific for the detection of amphetamines has been submitted, and the company is awaiting approval. Applications for the assays specific for PCP and marijuana are expected to be submitted by year-end.
 U.S. Drug Testing is a 67 percent owned subsidiary of U.S. Alcohol Testing of America Inc. (AMEX: AAA) and is engaged in the research and development of devices which detect drugs of abuse from urine and saliva samples.
 -0- 11/16/93
 /CONTACT: Gary S. Wolff, 909-466-8378/
 (AAA)


CO: U.S. Drug Testing Inc.; Naval Research Laboratory; U.S. Alcohol
 Testing of America Inc. ST: California IN: HEA SU:


LM-LS -- LA006 -- 4867 11/16/93 08:04 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 16, 1993
Words:291
Previous Article:THE INTIMACY STRUGGLE PROVIDES ANSWERS ABOUT RELATIONSHIPS
Next Article:GEMSTAR SUES STARSIGHT FOR PATENT MISUSE AND ANTITRUST VIOLATIONS; LAWSUIT TO RENDER ALL STARSIGHT PATENTS UNENFORCEABLE
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters